OUR STORY
Our story is a fusion of years of experience and knowledge, where a seasoned biotech and pharmaceutical executive along with an accomplished cannabis entrepreneur joined forces to redefine the role of cannabis in modern medicine. Due to our different experiences and backgrounds resulting in a powerhouse of synergies, and a shared a vision to connect the dots to address an unmet need in the marketplace. We represent the exciting possibilities that emerge when diverse skills unite towards a common goal. Join us as we continue to challenge perceptions and unlock the potential of cannabis in healthcare.
Our Mission
To improve global healthcare by accelerating the pathway and adoption of prescription and over the counter cannabinoid therapeutics, fostering a new era of medical possibilities.
Our Vision
To be the premier firm specializing in cannabinoid research, navigating global frameworks, and regulatory strategies to expedite approval of cannabinoid drugs and commercial market entries.
Our Founders
Lisa Rich-Milan
Founder & CEO
Highly accomplished and experienced CEO in pharmaceuticals & biotech.
​
-
Former CEO Maridose LLC
-
1 of 8 DEA bulk cannabis manufacturers
-
-
​Former CEO and BOD Caligor Coghlan Pharma Services​​ (Clinical Trials & EAP)
-
Former GM Diversigen (Microbiome Lab Services)
-
Former CEO and BOD CompuNet Clinical Labs (Quest Diagnostics)
-
Former GM of North America, Synthon Pharmaceuticals (Generic & Biosimilar Company)
-
Former Executive, Bristol Myers Squibb, UCB, Roche Diagnostics
Michael Zaccaria
Founder & COO
Accomplished executive in cannabinoid science and consumer product development.
​
-
Former CEO Focus Hemp Co (Cannabinoid Science & CPG)
-
Founder: True Herbal Creations (Consumer Products)
-
Founder: Grey Bear Solutions (Cannabis Consulting)
-
6+ Years Cannabis Industry Consulting
-
International Cannabinoid Science
-
10 - Year cannanbis entreprenure with two sucessful exits
-
Experienced in cannabinoid science, new product development, project management & executive leadership.
Our Chief Scientific Officer
Dr James Linden PhD
Head of Psychedelics Division & CSO
-
PhD Biochemist and serial entrepreneur in the plant medicine and MedTech spaces
-
Founder and CEO of GreenLight Pharmaceuticals Ltd (Cannabinoid pharmaceutical development in Ireland and UK)
-
Founder: Alvarius Pharmaceuticals Ltd (psychedelic clinical research into addiction and neurodegenerative diseases)
-
Founder: Éireceutica Ltd (generic pharmaceutical company in Ireland focused on novel POM to P switches)
-
11 Years Psychedelics and Cannabis Industry Consulting
-
Experienced in pharmaceutical development of cannabinoids and psychedelics
-
Co-supervised 10 PhD students all researching cannabis and psychedelics
-
Co-authored a recent book called Psychedelics as Psychiatric Medications with Professor David Nutt, leading figure in psychedelic research globally
Our Board of Advisors
Dedication. Expertise. Passion.
Our board of advisors comprises a diverse group of experts spanning various fields crucial for the commercialization of new therapeutics. From biotech veterans to pharmaceutical industry leaders, their collective expertise forms a solid foundation. With their guidance, we navigate the complexities of development, regulation, marketing, and beyond, ensuring that our clients reach their full potential in the complex landscapes of healthcare and cannabis.
_edited.png)